Stuart Ashman, CEO of SkinBioTherapeutics, expressed excitement about the launch, noting the anticipation from the team and investors. He highlighted Croda’s claim that Zenakine™ is the first ...

Tate & Lyle has announced that Steve Foots, Chief Executive of specialty ingredients giant Croda International, will join its ...

Croda International stock opened at GBX 2,923 ($37.76) on Tuesday. The company has a market cap of £4.09 billion, a PE ratio of 25.12, a PEG ratio of 1.40 and a beta of 0.74. The company has a ...

So it’s been another transitional year for Croda following two exceptionally strong years in ‘21 and ‘22. Sales growth was weaker than we’d hoped, but proactive actions to cost and drive ...